OnQuality Announces FDA Clearance of IND Application for OQL036 for the Prophylaxis of Capecitabine-Induced Hand-Foot Syndrome

SEATTLE, April 28, 2023 /PRNewswire/ — OnQuality Pharmaceuticals (“OnQuality”), a targeted oncology supportive therapy company developing innovative medications to address unmet needs in oncodermatology and oncogastroenterology (cancer therapy-induced toxicities occurring in the skin and…